Literature DB >> 28055310

Gastrointestinal stromal tumors (GIST): Facing cell death between autophagy and apoptosis.

Gloria Ravegnini1, Giulia Sammarini1, Margherita Nannini2, Maria A Pantaleo2,3, Guido Biasco2,3, Patrizia Hrelia1, Sabrina Angelini1.   

Abstract

Autophagy and apoptosis are 2 fundamental biological mechanisms that may cooperate or be antagonistic, although both are involved in deciding the fate of cells in physiological or pathological conditions. These 2 mechanisms coexist simultaneously in cells and share common upstream signals and stimuli. Autophagy and apoptosis play pivotal roles in cancer development. Autophagy plays a key function in maintaining tumor cell survival by providing energy during unfavorable metabolic conditions through its recycling mechanism, and supporting the high energy requirement for metabolism and growth. This review focuses on gastrointestinal stromal tumors and cell death through autophagy and apoptosis, taking into account the involvement of both of these processes in tumor development and growth and as mechanisms of drug resistance. We also focus on the crosstalk between autophagy and apoptosis as an emerging field with major implications for the development of novel therapeutic options.

Entities:  

Keywords:  GIST; apoptosis; autophagy; imatinib; miRNA

Mesh:

Year:  2017        PMID: 28055310      PMCID: PMC5361605          DOI: 10.1080/15548627.2016.1256522

Source DB:  PubMed          Journal:  Autophagy        ISSN: 1554-8627            Impact factor:   16.016


  105 in total

1.  Focusing on autophagy.

Authors: 
Journal:  Nat Cell Biol       Date:  2010-09       Impact factor: 28.824

Review 2.  Mechanisms of secondary resistance to tyrosine kinase inhibitors in gastrointestinal stromal tumours (Review).

Authors:  Alessandra Maleddu; Maria A Pantaleo; Margherita Nannini; Monica Di Battista; Maristella Saponara; Cristian Lolli; Guido Biasco
Journal:  Oncol Rep       Date:  2009-06       Impact factor: 3.906

3.  MicroRNA-494 downregulates KIT and inhibits gastrointestinal stromal tumor cell proliferation.

Authors:  Won Kyu Kim; Misun Park; Young-Kook Kim; You Kwon Tae; Han-Kwang Yang; Jae Myun Lee; Hoguen Kim
Journal:  Clin Cancer Res       Date:  2011-10-31       Impact factor: 12.531

4.  Molecular correlates of imatinib resistance in gastrointestinal stromal tumors.

Authors:  Michael C Heinrich; Christopher L Corless; Charles D Blanke; George D Demetri; Heikki Joensuu; Peter J Roberts; Burton L Eisenberg; Margaret von Mehren; Christopher D M Fletcher; Katrin Sandau; Karen McDougall; Wen-bin Ou; Chang-Jie Chen; Jonathan A Fletcher
Journal:  J Clin Oncol       Date:  2006-09-05       Impact factor: 44.544

5.  Primary and secondary kinase genotypes correlate with the biological and clinical activity of sunitinib in imatinib-resistant gastrointestinal stromal tumor.

Authors:  Michael C Heinrich; Robert G Maki; Christopher L Corless; Cristina R Antonescu; Amy Harlow; Diana Griffith; Ajia Town; Arin McKinley; Wen-Bin Ou; Jonathan A Fletcher; Christopher D M Fletcher; Xin Huang; Darrel P Cohen; Charles M Baum; George D Demetri
Journal:  J Clin Oncol       Date:  2008-10-27       Impact factor: 44.544

6.  Polymorphisms in DNA repair genes in gastrointestinal stromal tumours: susceptibility and correlation with tumour characteristics and clinical outcome.

Authors:  Gloria Ravegnini; Margherita Nannini; Vittorio Simeon; Muriel Musti; Giulia Sammarini; Maristella Saponara; Lidia Gatto; Milena Urbini; Annalisa Astolfi; Guido Biasco; Maria A Pantaleo; Nicola Venturoli; Patrizia Hrelia; Sabrina Angelini
Journal:  Tumour Biol       Date:  2016-07-27

7.  Mechanisms of oncogenic KIT signal transduction in primary gastrointestinal stromal tumors (GISTs).

Authors:  Anette Duensing; Fabiola Medeiros; Bryna McConarty; Nora E Joseph; Dipak Panigrahy; Samuel Singer; Christopher D M Fletcher; George D Demetri; Jonathan A Fletcher
Journal:  Oncogene       Date:  2004-05-13       Impact factor: 9.867

8.  p53 status and the efficacy of cancer therapy in vivo.

Authors:  S W Lowe; S Bodis; A McClatchey; L Remington; H E Ruley; D E Fisher; D E Housman; T Jacks
Journal:  Science       Date:  1994-11-04       Impact factor: 47.728

Review 9.  Pharmacogenetics of tyrosine kinase inhibitors in gastrointestinal stromal tumor and chronic myeloid leukemia.

Authors:  Gloria Ravegnini; Giulia Sammarini; Sabrina Angelini; Patrizia Hrelia
Journal:  Expert Opin Drug Metab Toxicol       Date:  2016-05-17       Impact factor: 4.481

10.  Inhibitor of Apoptosis Proteins (IAPs) are commonly dysregulated in GIST and can be pharmacologically targeted to enhance the pro-apoptotic activity of imatinib.

Authors:  Johanna Falkenhorst; Susanne Grunewald; Thomas Mühlenberg; Adrian Marino-Enriquez; Anna-Carina Reis; Christopher Corless; Michael Heinrich; Jürgen Treckmann; Lars Erik Podleska; Martin Schuler; Jonathan Alfred Fletcher; Sebastian Bauer
Journal:  Oncotarget       Date:  2016-07-05
View more
  21 in total

1.  Long-term adjuvant treatment of gastrointestinal stromal tumors (GIST) with imatinib-a comment and reflection on the PERSIST-5 study.

Authors:  Silke Cameron
Journal:  Transl Gastroenterol Hepatol       Date:  2018-03-14

2.  Chloroquine Combined with Imatinib Overcomes Imatinib Resistance in Gastrointestinal Stromal Tumors by Inhibiting Autophagy via the MAPK/ERK Pathway.

Authors:  Song Zheng; Yefei Shu; Yidan Lu; Yangcheng Sun
Journal:  Onco Targets Ther       Date:  2020-07-02       Impact factor: 4.147

Review 3.  Development of Molecular Mechanisms and Their Application on Oncolytic Newcastle Disease Virus in Cancer Therapy.

Authors:  Fang Huang; Chuanjing Dai; Youni Zhang; Yuqi Zhao; Yigang Wang; Guoqing Ru
Journal:  Front Mol Biosci       Date:  2022-07-04

4.  Autophagy impairment contributes to PBDE-47-induced developmental neurotoxicity and its relationship with apoptosis.

Authors:  Pei Li; Rulin Ma; Lixin Dong; Luming Liu; Guoyu Zhou; Zhiyuan Tian; Qian Zhao; Tao Xia; Shun Zhang; Aiguo Wang
Journal:  Theranostics       Date:  2019-06-09       Impact factor: 11.556

5.  Inhibition of EZH2 and EGFR produces a synergistic effect on cell apoptosis by increasing autophagy in gastric cancer cells.

Authors:  Youping Yang; Feng Zhu; Qingmei Wang; Yan Ding; Rongbiao Ying; Linghui Zeng
Journal:  Onco Targets Ther       Date:  2018-11-29       Impact factor: 4.147

6.  Capsaicin induces apoptosis and autophagy in human melanoma cells.

Authors:  Haihan Chu; Meng Li; Xiuchun Wang
Journal:  Oncol Lett       Date:  2019-04-03       Impact factor: 2.967

7.  Ginsenoside Rb3 provides protective effects against cisplatin-induced nephrotoxicity via regulation of AMPK-/mTOR-mediated autophagy and inhibition of apoptosis in vitro and in vivo.

Authors:  Jing-Jing Xing; Jin-Gang Hou; Zhi-Na Ma; Zi Wang; Shen Ren; Ying-Ping Wang; Wen-Cong Liu; Chen Chen; Wei Li
Journal:  Cell Prolif       Date:  2019-05-16       Impact factor: 6.831

8.  Escin induces caspase-dependent apoptosis and autophagy through the ROS/p38 MAPK signalling pathway in human osteosarcoma cells in vitro and in vivo.

Authors:  Jian Zhu; Wei Yu; Bing Liu; Yitian Wang; Jianlin Shao; Junjie Wang; Kaishun Xia; Chengzhen Liang; Weijing Fang; Chenhe Zhou; Huimin Tao
Journal:  Cell Death Dis       Date:  2017-10-12       Impact factor: 8.469

9.  Betanodavirus B2 protein triggers apoptosis and necroptosis in lung cancer cells that suppresses autophagy.

Authors:  Hsuan-Wen Chiu; Yu-Chin Su; Jiann-Ruey Hong
Journal:  Oncotarget       Date:  2017-10-06

10.  Scutellarin Increases Cisplatin-Induced Apoptosis and Autophagy to Overcome Cisplatin Resistance in Non-small Cell Lung Cancer via ERK/p53 and c-met/AKT Signaling Pathways.

Authors:  Chao-Yue Sun; Ying Zhu; Xiao-Feng Li; Xie-Qi Wang; Li-Peng Tang; Zu-Qing Su; Cai-Yun Li; Guang-Juan Zheng; Bing Feng
Journal:  Front Pharmacol       Date:  2018-02-13       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.